Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 176 active Chronic Lymphocytic Leukemia trials
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Study Type: Interventional Phase 2
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Study Type: Interventional Phase 3
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Study Type: Interventional Phase 1
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Study Type: Interventional Phase 2
MEOI and HRQoL in CLL Patients Treated With BTKis
Study Type: Observational
A Trial of “Armored” CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies
Study Type: Interventional Phase 1
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
Study Type: Interventional Phase 2
There are 176 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now